The center aims to increase the number of patients who benefit from cancer-killing immunotherapy drugs. To do so, researchers will utilize genomics, machine learning and immunology, and “look further into the tumor microenvironment for answers,” according to Miriam Merad, MD, PhD, director of Mount Sinai’s Precision Immunology Institute.
“We want to understand how to model interactions between cancers and the immune system to help more people benefit from the life-saving potential of immunotherapy,” Benjamin Greenbaum, PhD, an assistant professor at Mount Sinai and director of the hub, said in a statement.
The center officially launched on May 9 and is a collaboration between the Precision Immunology Institute and the Tisch Cancer Institute.
More articles about health IT:
US indicts Chinese hacker for exposing 80M Anthem patient records
Harvard Business Review: Look at AI as a system-wide update, not a point solution
Genetic mutation linked to higher fatality rate in prostate cancer patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
